Stockreport

Evofem Biosciences Announces Last Patient Enrolled for AMPREVENCE, the Phase 2b Sexually Transmitted Infections Trial of Amphora

EVOFEM BIOSCIENCE INC  (EVFM) 
Last evofem bioscience inc earnings: 3/12 08:00 am Check Earnings Report
US:NASDAQ Investor Relations: evofem.com